USPH.NYSEU S Physical Therapy INC /NV

Form 4: U.S. Physical Therapy COO Graham Reeve Reports Sale of Shares and Updates Beneficial Ownership

Sentiment:

SEC Form 4 Filing

📋All filings for U S Physical Therapy INC /NV
🔒Login to Follow

Graham Reeve, COO of U.S. Physical Therapy, reports the sale of 530 shares of common stock at an average price of $78.08 and updates his beneficial ownership, including restricted stock grants.

Summary

  • Graham Reeve, the COO of U.S. Physical Therapy Inc., filed a Form 4 with the SEC on May 22, 2025.
  • The report details a transaction on May 21, 2025, where Reeve sold 530 shares of common stock at a weighted average price of $78.08.
  • The sale occurred in multiple transactions with prices ranging from $77.83 to $78.35 per share.
  • Following the reported transaction, Reeve directly owns 17,244 shares of common stock.
  • Reeve also indirectly owns 8,586 shares through the Reeve Trust.
  • The directly held shares include 17,244 shares granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan, which vest in installments through March 6, 2029, contingent on continued employment.
  • Reeve has granted Richard Binstein and Kate Venturina power of attorney for SEC filings related to U.S. Physical Therapy securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a stock sale by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This filing is a routine disclosure related to insider trading activities, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company executives.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
  • The sale of shares by a company executive is a common occurrence and doesn't necessarily indicate a negative outlook for the company.
  • Similar filings can be observed across the healthcare sector, including companies like ATI Physical Therapy and Select Medical Holdings, when their executives trade company stock.

Key Dates

DateDescription
February 25, 2025Date of Power of Attorney execution by Graham Reeve.
May 21, 2025Date of the stock sale transaction.
May 22, 2025Date of Form 4 filing.
August 20, 2025First vesting date for 1,948 restricted shares.
November 20, 2025Second vesting date for 1,948 restricted shares.
March 6, 2026Vesting date for 1,964 restricted shares.
May 20, 2026Vesting date for 1,324 restricted shares.
August 20, 2026Vesting date for 1,324 restricted shares.
November 20, 2026Vesting date for 1,324 restricted shares.
March 6, 2027Vesting date for 1,332 restricted shares.
May 20, 2027Vesting date for 1,012 restricted shares.
August 20, 2027Vesting date for 1,012 restricted shares.
November 20, 2027Vesting date for 1,012 restricted shares.
March 6, 2028Vesting date for 1,016 restricted shares.
May 20, 2028Vesting date for 506 restricted shares.
August 20, 2028Vesting date for 506 restricted shares.
November 20, 2028Vesting date for 506 restricted shares.
March 6, 2029Final vesting date for 510 restricted shares.

Keywords

Form 4, Beneficial Ownership, Graham Reeve, U.S. Physical Therapy, USPH, Stock Sale, Restricted Stock, COO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.